Oral Health and COVID 19NCT04391881
Oral Manifestation of COVID 19 Patient: A Cross Sectional Study on Egyptian Population
An observational study of Oral Health and COVID 19, run by Cairo University at 1 site in Egypt.
Trial summary
The oral manifestation of COVID 19 that could help in the diagnosis of patient Read more about this study
- Who is it for?
- Ages 18 to 60 years
- Conditions the study is for
- Oral Health and COVID 19
- How many people
- 500 participants
- Where
- 1 siteEgypt
- Study dates
- 30 May 2020to 30 Aug 2020
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- All sexes
- Adult
Study population: Egyptian population tested COVID positive either hospitalized or not
Who may be able to join
- Tested COVID positive
- No other chronic disease that has oral manifestation
- Above 18
Who cannot join
- Children
- Patient with no COVID positive
Trial locations and contacts
1 site in 1 country.
Egypt1 site, 1 recruiting
- Recruiting
Cairo university
Cairo, 2346
Dina Mounir Elkady, Phd, 01004297317
Rawda Hesham Abdel aziz, Phd
About this study
Official title: Oral Manifestation of COVID19
The oral manifestation of COVID 19 that could help in the diagnosis of patient
Read the detailed description
Oral ulceration,oral lesion,sensitivity that has been reported by patient tested positive for COVID 19
- Conditions
- Oral Health and COVID 19
- Medical subject headings
- COVID-19
What is being measured
The primary outcome is the main question the study is designed to answer.
Oral manifestation
The presence or absence or oral manifestation like ulcer burning sensation..will be measured by yes or no using a list of question
Measured: 1month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted18 May 2020
- Study start30 May 2020
- Primary completion30 Aug 2020 (estimated)
- Study completion30 Aug 2020 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Oral Health and COVID 19Studies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 500 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Dina mounir elkady, Cairo University
- Investigators
- Dina Mounir Elkady, Principal investigator, Lecturer at cairo ubiversity
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04391881
- Sponsor's protocol ID
- 54678
- Status last verified
- Jul 2020
- First submitted
- 14 May 2020
- Last updated
- 16 Jul 2020
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 16 Jul 2020. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Oral Manifestation of COVID19
- ClinicalTrials.gov ID
- NCT04391881
- Acronym / sponsor ID
- 54678
- Conditions
- Oral Health and COVID 19
- Study type
- Observational
- Recruitment status
- Unknown status
- Enrolment
- 500 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 30 May 2020 (actual)
- Primary completion
- 30 Aug 2020 (estimated)
- Study completion
- 30 Aug 2020 (estimated)
- First posted
- 18 May 2020 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The oral manifestation of COVID 19 that could help in the diagnosis of patient
Detailed description
Oral ulceration,oral lesion,sensitivity that has been reported by patient tested positive for COVID 19
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
Who may qualify
- Ages
- 18 to 60 years
- Sex
- All
- Age groups
- Adult
- Study population
- Egyptian population tested COVID positive either hospitalized or not
Key inclusion criteria (3 listed)
- Tested COVID positive
- No other chronic disease that has oral manifestation
- Above 18
Key exclusion criteria (2 listed)
- Children
- Patient with no COVID positive
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Oral manifestation
Time frame: 1month
The presence or absence or oral manifestation like ulcer burning sensation..will be measured by yes or no using a list of question
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 16 Jul 2020.
- Individual participant dataSharing planned: Undecided
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dina Mounir Elkady principal investigator
Lecturer at cairo ubiversity
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Oral Health and COVID 19, run by Cairo University at 1 site in Egypt.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 16 Jul 2020. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Dina Mounir Elkady, Phd (01004297317, Dina.elkady@dentistry.cu.edu.eg), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Oral manifestation (time frame: 1month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Jul 2020.